Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods
A partir de revues systématiques de la littérature, ce dossier présente les recommandations concernant les différentes stratégies (biomodulation, médicaments anti-inflammatoires, compléments nutritionnels, etc.) pour prévenir et/ou traiter une mucite buccale ou gastro-intestinale induite par les traitements chez les patients atteints d'un cancer
New studies and literature continue to emerge on the management of mucositis secondary to cancer therapy. The evidence-based clinical practice guidelines for mucositis were first published in 2004 and updated in 2007 and 2014 by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). The existing 2014 guidelines for mucositis are being updated in line with new literature to inform clinical practice. This paper describes the materials and methods employed for the comprehensive updates to the guidelines for managing mucositis.